期刊文献+

XELOX方案同期化疗联合调强适形放疗治疗复发和局部晚期直肠癌的护理 被引量:6

Nursing of Recurrent and Advanced Rectal Cancer Patients Receiving Concurrent XELOX Chemotherapy and Intensity Modulated Conformal Radiotherapy
下载PDF
导出
摘要 目的:探讨卡培他滨(Xeloda,希罗达)联合奥沙利铂(LOHP)(XELOX方案)同期化疗联合调强适形放疗治疗复发和局部晚期直肠癌的临床护理。方法:对32例复发和局部晚期直肠癌患者XELOX方案同期化疗联合调强适形放疗的临床资料进行回顾性分析,治疗前采取心理护理,治疗期间及治疗后采取相应的护理措施。结果:本组32例患者中CR 3例,PR 22例,总有效率为78.1%。主要不良反应为骨髓抑制、神经系统毒性、手足综合征、恶心呕吐、腹泻、放射性直肠炎及膀胱炎等,但均无Ⅲ度一Ⅳ度毒副反应发生。结论:XELOX.方案同期调强适形放疗治疗复发和局部晚期直肠癌配合有效的护理措施,能有效减轻放化疗的副反应,有利于患者的预后和康复,提高生存质量。 Objective: To discuss the nursing methods of recurrent and locally advanced rectal cancer patients receiving concurrent XELOX regimen(Xeloda plus LOHP) chemotherapy and intensity modulated conformal radiotherapy. Methods: Clinical records of 32 cases of recurrent and locally advanced rectal cancer accepting concurrent XELOX regimen chemotherapy and intensity modulated confonnal radiotherapy were analyzed. Nursing procedures including pre-therapy psychological nursing was used before therapy, and suitable nursing measures were used during and after treatment. Results: The overall effective rate was 78.1% with 3 cases got CR and 22 PR. The main side-effects included myelosuppression, neurotoxicity, hand-foot syndrome, nausea and vomiting, diarrhea, radiation proctitis, and cystitis. Conclusion: The concurrent XELOX regimen chemotherapy and intensity modulated conformal radiotherapy is proved effective in the treatment of recurrent and locally advanced rectal cancer. In order to accelerate the recovery of patients and improve their life qulities after chemoradiotherapy, appropriate nursing on the nutrition, skin, mouth, ostomy and psychological status of patients should be carried out to alleviate the side-effects.
作者 陈世梅 李莉
出处 《肿瘤预防与治疗》 2011年第4期176-179,共4页 Journal of Cancer Control And Treatment
关键词 卡培他滨 奥沙利铂 调强适形放疗 化疗 护理 直肠癌 Xeloda LOHP Intensity Modulated Conformal Radiotherapy Chemotherapy Nursing Rectal Cancer
  • 相关文献

参考文献8

  • 1张伟东,苗树军.我国恶性肿瘤死亡率流行病学特征分析[J].中国健康教育,2009,25(4):246-248. 被引量:140
  • 2Temple WJ, Settler EB. Locally recurrent rectal cancer: role of composite resection of extensive pelvic tumors with strategies for minimizing risk of recurrence[ J]. J Surg Onco1,2000,73:47-58.
  • 3储大同 张湘茹 李俊岭.晚期非小细胞肺癌的治疗-国外的现状和我们的经验[A].见:孙燕 储大同主编.中国临床肿瘤学教育专辑[M].北京:中国医药科技出版社,2000.72-76.
  • 4康瑞,高艳.直肠癌术后放射治疗过程中的护理干预[J].实用医药杂志,2006,23(6):707-708. 被引量:4
  • 5郭莹,张淑卿,赵健.结、直肠癌患者应用希罗达致手足综合征的临床观察与护理[J].现代护理,2006,12(16):1540-1541. 被引量:11
  • 6Diaz Rubio E, Evans TR, Tabemera J, et al. Capecitabine( Xelo- da) in combination with oxaliplation:a phase with advanced or me- tastatic solid tumors [J]. Ann 0ncol,2002,13(4) :558-565.
  • 7Myers czito B, Yin FF, Willettc. Advanced radiation therapy techonologies in the treatment of rectal and anal cancer:intensity modu- lated photo therapy and proton therapy [ J]. Clin colorectal Cancer,2007,6:348-356.
  • 8Twelves C, Collins S, Grieve R,et al. A randomized cross-over trial comparing patient preference for oral capecitabine and 5-fluoroura- cil/leucovorin regimens in patients with advanced eolorectal cancer [J]. Ann Oneol,2006,17(2) :239-245.

二级参考文献12

  • 1惠利,臧淑伟,马怡,丁红娟,彭光群,刘思园.口服希罗达不良反应的观察及护理[J].现代护理,2005,11(13):1050-1051. 被引量:18
  • 2World Health Organization. Cancer incidence, mortality and survival by site for 14 regions of the world [ R]. Geneva:Global Programme on Evidence for Health Policy Discussion Paper,2001.
  • 3卫生部.全国健康教育与健康促进工作规划纲要(1005-2010)[R].北京:卫生部,2004.
  • 4World Health Organization. World cancer report [ R]. Geneva: WHO, 2003.
  • 5Tonani M, Carvalho EC. Cancer risk and preventive behavior: persuasion as an intervention strategy [ J ]. Rev Lat Am Enfermagem. 2008,16(5) :864 -870.
  • 6Frieden TR, Myers JE, Krauskopf MS. A public health approach to winning the war against cancer[ J]. Oncologist,2008,17 : 17.
  • 7Meta analysis group in cancer.Toxicity of fluorouracil inpatients with advanced colorectal cancer:Effect of asministion schdule and prognostic factors[J].J Clin Oncol,1998,16:3 537.
  • 8Olver IN,Aisner J,Hament A,et al.A prospectivs study of topical dimetyl sulfoxide for treating anthracycline extravasation[J].J Clin Oncol,1988,6:1 732-1 735.
  • 9Lokich JJ,Moore C.Chemotherapy associated palmar plantarerythrodysesthesia syndrome[J].Ann Inter Mer,1984,101:798.
  • 10Abushllaih S,Saad ED,Munsell M,Hoff PM.Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitaine:a singel-institution experience[J].Cancer Invest,2002,20(1):3-10.

共引文献157

同被引文献38

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部